Because the literature documents an association between overexpression of CDC25B and drug and radiation resistance[33,34], we next assessed whether gemcitabine-resistant (gemR) PDX models of PDAC had higher levels of CDC25B than the parent tumor counterparts. This evidence concerns the gene CDC25B and neoplasm.